RPG Life Sciences Limited (BOM:532983)

Market Cap	43.61B +12.5%
Revenue (ttm)	7.34B +11.8%
Net Income	1.20B -34.5%
EPS	72.33 -34.5%
Shares Out	n/a
PE Ratio	36.45
Forward PE	33.16
Dividend	24.00 (0.91%)
Ex-Dividend Date	Jul 9, 2026

Volume	374
Open	2,644.80
Previous Close	2,662.60
Day's Range	2,625.05 - 2,682.40
52-Week Range	1,731.25 - 3,080.90
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 28, 2026

About RPG Life Sciences

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and domestic and international finished dosage formulations for various therapies, which inclu...

• Industry: Pharmaceutical Preparations
• Founded: 1968
• Employees: 1,366
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532983

Financial Performance

In fiscal year 2026, RPG Life Sciences's revenue was 7.08 billion, an increase of 8.28% compared to the previous year's 6.53 billion. Earnings were 1.15 billion, a decrease of -37.15%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 22, 2026

Data Sources Report a data error